Madrigal Pharmaceuticals, Inc. MDGL Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported convertible preferred stock outstanding shares of 2.4M in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares decreased by 0.0% year-over-year, from 2.4M to 2.4M.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s convertible preferred stock outstanding shares has grown at a 3.8% compound annual growth rate (CAGR), from 2M to 2.4M.
- What does convertible preferred stock outstanding shares mean?
- The number of preferred shares currently held by investors that can be converted into common stock.
- How do you interpret convertible preferred stock outstanding shares?
- High levels of outstanding convertible shares signal potential future dilution for common shareholders.
- How does convertible preferred stock outstanding shares compare across companies?
- Common in companies that utilize venture-style financing structures before or during public listing.